Jamie Smyth
@JamieSmythF
US Energy Editor for the Financial Times 🗽DM's open for scoops/ ideas/comments. Former Irish/ Oz / Brussels corr. Belfast man https://t.co/T4yYkANfYi
ID:251206909
http://www.ft.com 12-02-2011 17:20:32
6,8K Tweets
7,7K Followers
3,4K Following
Follow People
German industry unlikely to fully recover from energy crisis, even as gas prices fall, warns RWE boss
“You’re going to see a bit of recovery, but I think we’re going to see a significant structural demand destruction,” said Markus Krebber
w Jamie Smyth
ft.com/content/5d98bc…
Josh Shapiro warns Joe Biden gas stance could hurt election hopes via Financial Times
From Jamie Smyth and Lauren Fedor on.ft.com/4cOD00I
AI revolution will be boon for natural gas, say fossil fuel bosses, as rapid data center roll out prompts surge in power demand ft.com/content/1f93b9… via @ft Myles McCormick Amanda Chu
World’s largest oilfield services group has no plans to leave Russia Financial Times
Two years and a bit since Russia’s full scale invasion of Ukraine, Schlumberger (aka SLB) has not yet decided to leave Russia. By Jamie Smyth and Myles McCormick on.ft.com/49bpMIh
World's biggest oilfield services group Houston-based SLB says it has no plans to leave Russia despite the the war in Ukraine. Its biggest rivals Baker Hughes and Halliburton sold up in 2022 Financial Times ft.com/content/874141… via @ft Myles McCormick
Oil executives talk down rapid shift to green energy as profits boom, saying consumers are unwilling to pay for the transition despite rising alarm over climate change Myles McCormick Amanda Chu CERAWeek ft.com/content/2379f0… via @ft
Oil and gas executives expect slower transition to net zero- our latest Financial Times Energy Source newsletter provides an insight into industry thinking ahead of the big CERAWeek conference next week Amanda Chu ft.com/content/96a7fa… via @ft
💊 🚑 JOB NEWS 💊🚑 I’m moving to New York later this month to start covering US pharmaceuticals, biotech and healthcare for the Financial Times. I want to write about everything from drug pricing to scientific innovation to pharmacy benefit managers, so please get in touch with any ideas /1